0001553643 1 2026-06-17 2026-06-17 0001553643 2 2026-06-17 2026-06-17 0001553643 2026-06-17 2026-06-17 iso4217:USD pure shares S-8 EX-FILING FEES 0001553643 false false N/A S-8 Relmada Therapeutics, Inc. Equity Common stock, $0.001 par value per share: true 2000000 6.4280 12856000.00 0.0001381 1775.41 Equity Common stock, $0.001 par value per share: true 8328908 6.4280 53538220.62 0.0001381 7393.63 66394220.62 9169.04 0.00 9169.04 Represents additional shares of common stock, $0.001 par value per share (“Common Stock”), of Relmada Therapeutics, Inc. (the “Company”) reserved for issuance under the Company’s 2021 Equity Incentive Plan (as amended, the “2021 Plan”). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an additional indeterminate amount of shares to be offered or sold pursuant to the 2021 Plan and shares that may become issuable under the 2021 Plan by reason of certain corporate transactions or events, including any share dividend, share split, recapitalization or any other similar adjustment of the outstanding Common Stock.<br/><br/>Represents the number of shares and shares issuable pursuant to stock option awards outstanding under the 2021 Plan.<br/><br/>Estimated pursuant to Rule 457(h) solely for purposes of calculating the aggregate offering price and the amount of the registration fee based upon a weighted average of the exercise prices of outstanding options previously granted. Represents additional shares of common stock, $0.001 par value per share (“Common Stock”), of Relmada Therapeutics, Inc. (the “Company”) reserved for issuance under the Company’s 2021 Equity Incentive Plan (as amended, the “2021 Plan”). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers an additional indeterminate amount of shares to be offered or sold pursuant to the 2021 Plan and shares that may become issuable under the 2021 Plan by reason of certain corporate transactions or events, including any share dividend, share split, recapitalization or any other similar adjustment of the outstanding Common Stock.<br/><br/>Represents the number of shares and shares issuable pursuant to stock option awards available for future awards under the 2021 Plan.<br/><br/>Estimated solely for the purpose of calculating the registration fee computed pursuant to Rule 457(c) and (h), upon the average of the high and low prices of the Company’s common stock of $6.428, quoted on the Nasdaq stock Market on 16, 2026.